1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Real-Time PCR
1.2.3 Digital PCR
1.3 Market by Application
1.3.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Japan Growth Trends
2.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Perspective (2017-2028)
2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Dynamics
2.2.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industry Trends
2.2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
2.2.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Challenges
2.2.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Players
3.1.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Players (2017-2022)
3.1.2 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue
3.4 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Ratio
3.4.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Japan Top 3 and Top 5 Companies by Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue in 2021
3.5 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Key Players Head office and Area Served
3.6 Key Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Solution and Service
3.7 Date of Enter into Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Breakdown Data by Type
4.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Type (2017-2022)
4.2 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Type (2023-2028)
5 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Breakdown Data by Application
5.1 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Historic Market Size by Application (2017-2022)
5.2 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecasted Market Size by Application (2023-2028)
6 Key Players Profiles
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Details
6.1.2 Thermo Fisher Scientific Business Overview
6.1.3 Thermo Fisher Scientific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
6.1.4 Thermo Fisher Scientific in Japan: Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2017-2022)
6.1.5 Thermo Fisher Scientific Recent Development
6.2 Roche
6.2.1 Roche Company Details
6.2.2 Roche Business Overview
6.2.3 Roche Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
6.2.4 Roche in Japan: Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2017-2022)
6.2.5 Roche Recent Development
6.3 Bio-rad
6.3.1 Bio-rad Company Details
6.3.2 Bio-rad Business Overview
6.3.3 Bio-rad Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
6.3.4 Bio-rad in Japan: Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2017-2022)
6.3.5 Bio-rad Recent Development
6.4 Qiagen
6.4.1 Qiagen Company Details
6.4.2 Qiagen Business Overview
6.4.3 Qiagen Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
6.4.4 Qiagen in Japan: Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2017-2022)
6.4.5 Qiagen Recent Development
6.5 Agilent
6.5.1 Agilent Company Details
6.5.2 Agilent Business Overview
6.5.3 Agilent Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Introduction
6.5.4 Agilent in Japan: Revenue in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Business (2017-2022)
6.5.5 Agilent Recent Development
7 Analyst’s Viewpoints/Conclusions
8 Appendix
8.1 Research Methodology
8.1.1 Methodology/Research Approach
8.1.2 Data Source
8.2 Disclaimer
8.3 Author Details
日本のPOC診断用PCR市場2022 |
| 【英語タイトル】Japan Polymerase Chain Reaction (PCR) For Point-Of-Care (POC) Diagnostics Market Research Report 2022 | |
 | ・商品コード：HNI519JP388 ・発行会社（調査会社）：QYResearch ・発行日：2022年5月 ・ページ数：約90 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後3営業日） ・調査対象地域：日本 ・産業分野：医療機器 |
| Single User（1名様閲覧用） | USD3,400 ⇒換算￥496,400 | 見積依頼/購入/質問フォーム |
| Multi User（5名様閲覧用） | USD5,100 ⇒換算￥744,600 | 見積依頼/購入/質問フォーム |
| Enterprise License（法人閲覧用） | USD6,800 ⇒換算￥992,800 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
Due to the COVID-19 pandemic, the Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size is estimated to be worth US$ xx million in 2022 and is forecast to a readjusted size of US$ xx million by 2028 with a CAGR of xx% during the review period. Fully considering the economic change by this health crisis, Real-Time PCR accounting for xx% of the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Japan market in 2021, is projected to value US$ xx million by 2028, growing at a revised xx% CAGR in the post-COVID-19 period. While Hospitals segment is altered to an xx % CAGR throughout this forecast period.
In Japan, the key manufacturers of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics include Thermo Fisher Scientific, Roche, Bio-rad, Qiagen, Agilent, and etc. In 2021, the top five players have a share approximately XX% in terms of revenue.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
Segment by Type
Real-Time PCR
Digital PCR
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Company
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
| ★調査レポート[日本のPOC診断用PCR市場2022] (コード：HNI519JP388)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[日本のPOC診断用PCR市場2022]についてメールでお問い合わせ |
